The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
Version 2 2024-06-06, 08:19Version 2 2024-06-06, 08:19
Version 1 2021-11-12, 08:08Version 1 2021-11-12, 08:08
journal contribution
posted on 2024-06-06, 08:19authored bySR Susai, D Mongan, C Healy, M Cannon, B Nelson, C Markulev, MR Schäfer, M Berger, N Mossaheb, M Schlögelhofer, S Smesny, IB Hickie, GE Berger, EYH Chen, L de Haan, DH Nieman, M Nordentoft, A Riecher-Rössler, S Verma, A Thompson, Alison YungAlison Yung, PD McGorry, M Föcking, D Cotter, GP Amminger
The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial